West Pharmaceutical Services Inc (WST) income statement
WSTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3031% above fair value
$404.02−10.10 (-2.44%)
Close on Nov 18, 2026Market cap $28.14BP/E 45.3Yield 0.21%
West Pharmaceutical Services Inc income statement
Ratios
Latest available, balances at Sep 30, 2026
Profitability, TTM
- Gross margin
- 37.6%
- Operating margin
- 23.0%
- Net margin
- 18.8%
- Return on equity, FY2025
- 16.9%
Financial strength
- Current ratio
- 2.82
- Debt to equity
- 0.07
- Debt to assets
- 5.0%
- Cash to current liabilities
- 72.0%
Valuation
- P/E ratio
- 45.3
- Price to sales
- 8.29
- Price to book
- 9.48
- Dividend yield
- 0.21%
See a number that looks wrong?